Ahmed Y Azzam

27PUBLICATIONS
80CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursBiologically active moleculesMolecular targetsSatisfiability and optimisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 18, 2026
Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

|Sep 02, 2026
Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality.

|Aug 14, 2026
Glucagon-Like Peptide-1 Receptor Agonists for Patients with Conservatively Managed Nontraumatic Subdural Hematoma.

|Jul 13, 2026
GLP-1 RA Plus SGLT2i Versus Monotherapy in MASLD and Type 2 Diabetes: Three Pairwise Target Trial Emulations.

|May 26, 2026
Association of Glucagon-like Peptide-1 Receptor Agonist Use with Stroke and Mortality Outcomes in Asymptomatic Intracranial Atherosclerotic Disease: Propensity Score-Matched Real-World Analysis.

|May 21, 2026
GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity.

Pageof 5

Frequent Collaborators

8 joint publications

Adam A Dmytriw

8 joint publications

Muhammed Amir Essibayi

6 joint publications

Ajay Malhotra

6 joint publications

Dhairya A Lakhani